ADVERTISEMENT

Psychedelics News

Diamond Therapeutics

Industry

24 Jan 2023

Health Canada Approves Diamond Therapeutics’ Phase 2 Trial of Low-Dose Psilocybin

Diamond Therapeutics Phase 2 trial has been approved by Health Canada, a four-week, Phase 2 randomized, double-blind study in adult patients with Generalized Anxiety Disorder...

By Microdose NewsDesk

Events

29 Oct 2021

Microdose Announces Diamond Therapeutics as Wonderland Silver Sponsor

It’s an honor for Microdose to announce Diamond Therapeutics as a Silver Sponsor of Wonderland: Miami 2021....

By Microdose

ADVERTISEMENT

Follow us on social

Latest News

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads